【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Product Profiles
04.1 Soliris
04.2 Nplate
04.3 Revlimid
04.4 Vidaza
04.5 Promacta
04.6 Jakafi
04.7 Rituxan
05.Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06.Introduction
07.Diseases Overview
07.1 ITP
07.1.1 Understanding the Disease
07.1.2 Epidemiology
07.1.3 Etiology
07.1.4 Pathophysiology
07.1.5 Management of Disease
07.2 MDS
07.2.1 Understanding the Disease
07.2.2 Epidemiology
07.2.3 Etiology
07.2.4 Pathophysiology
07.2.5 Management of Disease
07.3 MF
07.3.1 Understanding the Disease
07.3.2 Epidemiology
07.3.3 Etiology
07.3.4 Pathophysiology
07.3.5 Management of Disease
07.4 PNH
07.4.1 Understanding the Disease
07.4.2 Epidemiology
07.4.3 Etiology
07.4.4 Pathophysiology
07.4.5 Management of Disease
07.5 PV
07.5.1 Understanding the Disease
07.5.2 Epidemiology
07.5.3 Etiology
07.5.4 Pathophysiology
07.5.5 Management of Disease
07.6 Pipeline Analysis
07.7 Emerging Treatment Options
08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09.Market Segmentation by Indication Type
09.1.1 Market Size and Forecast for ITP
09.1.2 Market Size and Forecast for MDS
09.1.3 Market Size and Forecast for MF
09.1.4 Market Size and Forecast for PNH
09.1.5 Market Size and Forecast for PV
10.Geographical Segmentation
11.Buying Criteria
12.Market Growth Drivers
13.Drivers and their Impact
14.Market Challenges
15.Impact of Drivers and Challenges
16.Market Trends
17.Trends and their Impact
18.Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2014
18.2.1 Competitive Assessment of Top Drugs
18.2.2 Alexion Pharmaceuticals
18.2.3 Amgen
18.2.4 Celgene
18.2.5 F. Hoffmann-La Roche
18.2.6 GlaxoSmithKline
18.2.7 Incyte
Other Prominent Vendors
19.Key Vendor Analysis
19.1 F. Hoffmann-La Roche Ltd.
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Business Segmentation
19.1.4 Business Segmentation by Revenue 2012 and 2013
19.1.5 Sales by Geography
19.1.6 Business Strategy
19.1.7 Key Information
19.1.8 SWOT Analysis
19.2 Celgene
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Business Strategy
19.2.4 Business Segmentation by Revenue
19.2.5 Sales by Geography
19.2.6 Key Information
19.2.7 SWOT Analysis
19.3 Alexion
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Geographical Segmentation by Revenue 2013
19.3.4 Business Strategy
19.3.5 Recent Developments
19.3.6 SWOT Analysis
19.4 Amgen
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Business Segmentation by Revenue 2013
19.4.4 Product Portfolio by Revenue 2013
19.4.5 Business Segmentation by Revenue 2012 and 2013
19.4.6 Geographical Segmentation by Revenue 2013
19.4.7 Business Strategy
19.4.8 Recent Developments
19.4.9 SWOT Analysis
19.5 Incyte
19.5.1 Key Facts
19.5.2 Business Overview
19.5.3 Revenue Segmentation by 2013
19.5.4 Revenue Segmentation by 2012 and 2013
19.5.5 Geographical Segmentation
19.5.6 Business Strategy
19.5.7 Recent Developments
19.5.8 SWOT Analysis
19.6 GlaxoSmithKline
19.6.1 Key Facts
19.6.2 Business Overview
19.6.3 Business Segmentation
19.6.4 Business Segmentation by Revenue 2012 and 2013
19.6.5 Sales by Geography
19.6.6 Pipeline Products
19.6.7 Business Strategy
19.6.8 Key Information
19.6.9 SWOT Analysis
19.6.10 Strengths
19.6.11 Weaknesses
19.6.12 Opportunities
19.6.13 Threats
20.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Snapshot of ITP
Exhibit 3: Snapshot of MDS
Exhibit 4: Snapshot of MF
Exhibit 5: Snapshot of PNH
Exhibit 6: Snapshot of PV
Exhibit 7: Global Acquired Orphan Blood Diseases Therapeutics Market 2014-2019 (US$ million)
Exhibit 8: Global Acquired Orphan Blood Diseases Therapeutics Market Segmentation by Indication Type
Exhibit 9: Global Acquired Orphan Blood Diseases Therapeutics Market Revenue Comparison by Indication, 2014 and 2019 (US$ million)
Exhibit 10: Global Acquired Orphan Blood Diseases Therapeutics Market Percent Share by Indication, 2014 and 2019
Exhibit 11: Market Size and Forecast for ITP Market 2014-2019 (US$ million)
Exhibit 12: Market Size and Forecast for MDS Market 2014-2019 (US$ million)
Exhibit 13: Market Size and Forecast for MF Market 2014-2019 (US$ million)
Exhibit 14: Market Size and Forecast for PNH Market 2014-2019 (US$ million)
Exhibit 15: Market Size and Forecast for PV Market 2014-2019 (US$ million)
Exhibit 16: Geographical Segmentation of Global Acquired Orphan Blood Diseases Therapeutics Market in 2014
Exhibit 17: Marketing Exclusivity for Orphan Drugs in Some Regions
Exhibit 18: Revenue Comparison of Top Drugs for Acquired Orphan Blood Diseases Therapeutics market in 2013 (US$ million)
Exhibit 19: Revenue Comparison and YoY Growth for Soliris from 2012-2014 (US$ million)
Exhibit 20: Global Market Forecast for Soliris from 2014-2019 (US$ million)
Exhibit 21: Revenue Comparison and YoY Growth for Nplate from 2011-2013 (US$ million)
Exhibit 22: Revenue Comparison and YoY Growth for Revlimid from 2011-2013 (US$ million)
Exhibit 23: Revenue Comparison and YoY Growth for Vidaza from 2011-2013 (US$ million)
Exhibit 24: Revenue Comparison for Rituxan from 2012-2013 (US$ million)
Exhibit 25: Revenue Comparison and YoY Growth for Promacta 2011-2014 (US$ million)
Exhibit 26: Revenue Comparison for Jakafi from 2012-2013 (US$ million)
Exhibit 27: Business Segmentation of F. Hoffmann-La Roche Ltd. 2013
Exhibit 28: F. Hoffmann-La Roche Ltd.: Business Segmentation by Revenue 2012 and 2013
Exhibit 29: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 30: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Diagnostics Division)
Exhibit 31: Celgene: Business Segmentation by Revenue 2011-2013 (US$ million)
Exhibit 32: Celgene: Sales by Geography 2013
Exhibit 33: Alexion: Geographical Segmentation by Revenue 2013
Exhibit 34: Amgen: Business Segmentation by Revenue 2013
Exhibit 35: Amgen: Product Portfolio by Revenue 2013
Exhibit 36: Amgen: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 37: Amgen: Geographical Segmentation by Revenue 2013
Exhibit 38: Incyte Corporation: Revenue Segmentation by 2013 (US$ million)
Exhibit 39: Incyte Corporation: Revenue Segmentation by 2012 and 2013 (US$ million)
Exhibit 40: Incyte Corporation: Geographical Segmentation
Exhibit 41: GlaxoSmithKline: Business Segmentation 2013
Exhibit 42: GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 43: GlaxoSmithKline: Sales by Geography 2013
Exhibit 44: GlaxoSmithKline: Pipeline Products 2013
【レポート販売概要】
■ タイトル：後発性希少血液疾患治療薬の世界市場：PNH、ITP、PV、MF、MDS■ 英文：Global Acquired Orphan Blood Diseases Therapeutics Market 2015-2019
■ 発行日：2015年3月11日
■ 調査会社：Technavio
■ 商品コード：IRTNTR5409
■ 調査対象地域：グローバル
- ソノブイの世界市場2016-2020About Sonobuoy Sonobuoys are key aspects of naval forces and underwater acoustic research institutions. They are mainly deployed by ships and aircraft in the ocean to extract information about submarines of nemeses and mammals. Hydrophone sensors, sonar systems, radio transmitters, and receivers are some of the key components of sonobuoys. They are of three types: active, passive, and special purp …
- 自動車ブレーキ摩擦材の世界市場：ブレーキパッド、ブレーキシュー、ブレーキライニング、ブレーキロータ、ブレーキドラムThe automotive brake friction products market has witnessed considerable growth in countries such as China, India, and Brazil, owing to upcoming emission norms. Given the increased vehicle production and lifespan of vehicles, the demand for brake friction products is growing. In this research study, the automotive brake friction products market is segmented into three major segments: automotive br …
- カラー化粧品の世界市場2015-2019Technavio market research analyst predicts the global color cosmetics market to grow at a CAGR of around 5% during the forecast period. The rising consciousness about appearance among the younger population is driving the growth of the market globally. The engagement is high among women between the age of 25 to 34, who are interested in the benefits of the product and prefer long-lasting products …
- 世界の自動車シャシーダイナモメーター市場2015The Global Automotive Chassis Dynamometer Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Automotive Chassis Dynamometer industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Automotive Chassis Dynamometer market analysis is provided for the internati …
- フタル酸ジオクチル(DOP)の世界市場予測Dioctyl Phthalate (DOP) 2014 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about Dioctyl Phthalate (DOP) market in the all-in-one report issued in a logical and easily accessible format. In addition …
- ベビームーブメントモニターの世界市場2018-2022About Baby Movement Monitor Baby movement monitors sense the movements of a baby such as or breathing and set off alarms in the absence of movements after a certain duration. The adoption of baby movement monitors is increasing worldwide due to the introduction of new formats with additional features. Technavio’s analysts forecast the global baby movement monitor market to grow at a CAGR of 10.9% …
- 世界の全エクソーム配列決定（WES）市場予測：技術、用途The applications of whole exome sequencing (WES) technologies have witnessed growth in recent years, which can be primarily attributed to the availability of advanced systems as well as the low cost of conducting exome sequencing, as compared with that of whole genome sequencing. The technological advancement is evident from the number of improved versions of existing sequencers released in recent …
- 希土類金属の世界市場2017-2021ABSTRACTAbout Rare Earth Metals Rare earth metals comprise 17 chemical elements in the periodic table, which include fifteen elements of the lanthanide series, and scandium and yttrium. Scandium and yttrium are also considered rare earth metals as they are found in the same mineral ore deposits as the other elements of the lanthanide series. Rare earth metals have unique physical and chemical prop …
- 小児がん(Pediatric Cancer)：世界の治験レビュー（2015年上半期版）Pediatric Cancer Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Pediatric Cancer Global Clinical Trials Review, H1, 2015" provides data on the Pediatric Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pediatric Cancer. It includes an overview of the trial numbers and their recruitment statu …
- 小型衛星の世界市場：ナノ衛星、ミニ衛星、マイクロ衛星The small satellite market has been estimated to be worth USD 2.22 Billion in 2016 and is projected to be valued at USD 5.32 Billion by 2021, registering a CAGR of 19.14% during the forecast period. On the basis of type, the small satellite market is segmented into Nanosatellite, minisatellite, and microsatellite. In 2016, the minisatellite market is estimated to grow at the highest growth rate du …
- オーディエンスアナリティクスの世界市場：コンポーネント別（ソリューション、サービス）、用途別（販売・マーケティング管理、顧客経験管理、競合他社の特別情報）、組織サイズ別、垂直産業別、地域別予測Global Audience Analytics Market Size Study, by Component (Solution & Services.) by Application (Sales & Marketing Management, Customer Experience Management, & Competitive Intelligence), by Organization Size, by Vertical and by Region - Global Forecast 2017- 2025 Global Audience Analytics Market to reach USD xxxx billion by 2025. Global Audience Analytics Market valued approximately USD xxxx bill …
- 包装用フィルム市場（グローバル動向と予測）Packaging films are essential for quality and shelf-life of food, pharmaceutical, and other personal care products. Food packaging industry is the major consumer for packaging film followed by the pharmaceutical and medical packaging. These films are formed by extrusion-blown, extrusion-cast, and extrusion-coating process. Selection of the raw material is primarily based on the end-usage of the fi …
- てんかん重積状態治療のグローバル臨床試験動向（2014年下半期）Status Epilepticus Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Status Epilepticus Global Clinical Trials Review, H2, 2014" provides data on the Status Epilepticus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Status Epilepticus. It includes an overview of the trial numbers and their recruitme …
- 世界のヘルスケアIT市場動向（2012-2016）TechNavio's analysts forecast the Global Healthcare IT market to grow at a CAGR of 5.3 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing need to store patient information and use it to provide appropriate/better healthcare services. The Global Healthcare IT market has also been witnessing the increased application of mobile technology. H …
- 建設廃棄物管理サービスの世界市場2015-2019About construction waste management Globally, the construction industry plays a significant role in the growth of an economy; however, the waste generated through building activities can cause serious damage to the environment if not managed properly. Construction waste may include a wide range of unwanted materials and most of them can be potentially recycled and reused. Construction waste manage …
